CNTA Centessa Pharmaceuticals PLC

Fundamentals / CIK 0001847903 / USD

Centessa Pharmaceuticals PLC reported $0 in revenue and a net loss of $250.6M for the trailing twelve months ended March 31, 2026 (down 100.0% year over year).

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CNTA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

7 fiscal years (2019 to 2025), reported in USD.

$55.03M$27.51M$0-$357.6MFY 2019 Net Income: -$5.06M2019FY 2020 Net Income: -$10.66M2020FY 2021 Net Income: -$381.1M2021FY 2022 Revenue: $0FY 2022 Net Income: -$216.2M2022FY 2023 Revenue: $6.85MFY 2023 Net Income: -$151.1M2023FY 2024 Revenue: $0FY 2024 Net Income: -$235.8M2024FY 2025 Revenue: $15.00MFY 2025 Net Income: -$197.5M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $15.00M $0 $6.85M $0 -- -- --
Research & Development $172.2M $150.2M $124.4M $155.1M $95.66M $9.30M $4.26M
Operating Income -$207.7M -$201.1M -$171.3M -$212.3M -$374.1M -$10.44M -$5.05M
EBITDA -$206.8M -$200.1M -$170.5M -$212.1M -$374.1M -$10.44M -$5.05M
Interest Income $20.53M $14.02M $10.48M -- -- -- --
Interest Expense $11.46M $10.09M $9.91M $7.28M -- -- --
Income Before Tax -$195.7M -$232.9M -$176.1M -$217.0M -$381.0M -$10.66M -$5.06M
Income Tax Expense $1.82M $2.84M -$25.06M -$747K $114K $0 $0
Net Income -$197.5M -$235.8M -$151.1M -$216.2M -$381.1M -$10.66M -$5.06M
Basic EPS -$1.46 -$2.06 -$1.57 -$2.31 -$5.07 -- --
Diluted EPS -$1.46 -$2.06 -$1.57 -$2.31 -$5.07 -- --
Basic Shares Outstanding 135.7M 114.5M 96.2M 93.4M 75.2M -- --
Diluted Shares Outstanding 135.7M 114.5M 96.2M 93.4M 75.2M -- --

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Revenue $0 $0 $0 $0 $15.00M $0 $0 $0
Research & Development $59.89M $54.48M $41.56M $42.74M $33.44M $60.87M $33.90M $32.81M
Operating Income -$79.77M -$68.47M -$53.79M -$54.65M -$30.78M -$74.58M -$46.41M -$43.98M
EBITDA -$79.53M -$68.23M -$53.55M -$54.43M -$30.56M -$74.35M -$46.17M -$43.74M
Interest Income $5.14M $4.49M $3.77M $4.38M $7.89M $4.84M $3.34M $3.24M
Interest Expense $2.73M $2.81M $2.89M $2.88M $2.88M $2.48M $2.56M $2.52M
Income Before Tax -$78.39M -$66.69M -$54.73M -$49.56M -$24.74M -$110.3M -$41.96M -$43.11M
Income Tax Expense $850K -$522K $166K $778K $1.40M $1.05M $608K $705K
Net Income -$79.24M -$66.16M -$54.89M -$50.34M -$26.14M -$111.3M -$42.57M -$43.82M
Basic EPS -$0.52 -- -$0.41 -$0.38 -$0.20 -- -$0.37 -$0.40
Diluted EPS -$0.52 -- -$0.41 -$0.38 -$0.20 -- -$0.37 -$0.40
Basic Shares Outstanding 153.5M -- 134.2M 133.7M 133.0M -- 116.3M 109.5M
Diluted Shares Outstanding 153.5M -- 134.2M 133.7M 133.0M -- 116.3M 109.5M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $61.30M $383.2M $128.0M $393.6M $595.1M $7.23M
Short-Term Investments $233.3M $98.96M $128.5M $0 -- --
Cash & Short-Term Investments $294.6M $482.2M $256.5M $393.6M $595.1M $7.23M
Other Current Assets $1.83M $1.50M $1.62M $3.27M $993K $6.0K
Total Current Assets $367.9M $536.4M $315.1M $437.7M $628.8M $11.16M
Property, Plant & Equipment, Net $807K $744K $1.04M $1.17M $162K $0
Other Non-Current Assets $1.44M $2.05M $2.55M $1.88M $699K $552K
Total Non-Current Assets $319.6M $40.39M $45.15M $6.56M $861K $552K
Total Assets $687.5M $576.8M $360.2M $444.3M $629.6M $11.72M
Accounts Payable $7.58M $7.14M $11.81M $13.84M $8.06M $1.03M
Short-Term Debt -- -- -- -- -- $5.63M
Total Current Liabilities $42.94M $58.00M $39.38M $38.34M $24.64M $8.62M
Long-Term Debt $110.1M $108.9M $75.70M $69.80M $75.70M $0
Other Non-Current Liabilities $29K $29K $29K $0 $43K $0
Total Non-Current Liabilities $117.7M $117.3M $84.62M $69.80M $113.4M $0
Total Liabilities $160.6M $175.3M $124.0M $108.1M $138.1M $8.62M
Total Debt (incl. Leases) $118.4M $117.8M $85.09M $69.80M $75.70M $5.63M
Common Stock $405K $359K $273K $265K $252K --
Retained Earnings -$1.19B -$988.7M -$752.9M -$601.9M -$385.7M --
Accumulated Other Comp. Income $2.71M $4.21M $1.49M -$1.50M $688K --
Total Stockholders' Equity $526.9M $401.5M $236.2M $336.2M $491.6M --
Total Equity $526.9M $401.5M $236.2M $336.2M $491.6M --

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Cash & Cash Equivalents $62.43M $61.30M $50.81M $44.24M $105.2M $383.2M $395.0M $127.4M
Short-Term Investments $214.2M $233.3M $195.4M $206.5M $179.3M $98.96M $123.4M $167.5M
Cash & Short-Term Investments $276.6M $294.6M $246.2M $250.7M $284.5M $482.2M $518.4M $294.8M
Other Current Assets $2.12M $1.83M $2.76M $1.62M $1.61M $1.50M $2.67M $1.95M
Total Current Assets $348.7M $367.9M $307.7M $300.4M $347.7M $536.4M $568.4M $355.5M
Property, Plant & Equipment, Net $722K $807K $894K $733K $681K $744K $821K $903K
Other Non-Current Assets $1.28M $1.44M $1.59M $1.72M $1.88M $2.05M $2.23M $2.38M
Total Non-Current Assets $293.1M $319.6M $140.6M $191.8M $180.1M $40.39M $41.35M $43.34M
Total Assets $641.8M $687.5M $448.3M $492.1M $527.8M $576.8M $609.7M $398.8M
Accounts Payable $10.66M $7.58M $8.68M $5.69M $5.13M $7.14M $7.44M $5.32M
Total Current Liabilities $36.57M $42.94M $29.12M $29.69M $24.20M $58.00M $26.41M $26.75M
Long-Term Debt $110.4M $110.1M $109.8M $109.5M $109.3M $108.9M $75.70M $76.50M
Other Non-Current Liabilities $29K $29K $29K $29K $29K $29K $29K $29K
Total Non-Current Liabilities $117.8M $117.7M $117.6M $117.5M $117.4M $117.3M $84.17M $85.12M
Total Liabilities $154.4M $160.6M $146.7M $147.2M $141.6M $175.3M $110.6M $111.9M
Total Debt (incl. Leases) $118.6M $118.4M $118.3M $118.1M $118.0M $117.8M $84.72M $85.65M
Common Stock $419K $405K $364K $363K $362K $359K $357K $309K
Retained Earnings -$1.27B -$1.19B -$1.12B -$1.07B -$1.01B -$988.7M -$877.4M -$834.8M
Accumulated Other Comp. Income $1.41M $2.71M $2.60M $1.59M $2.08M $4.21M $2.10M $1.59M
Total Stockholders' Equity $487.3M $526.9M $301.6M $344.9M $386.2M $401.5M $499.1M $287.0M
Total Equity $487.3M $526.9M $301.6M $344.9M $386.2M $401.5M $499.1M $287.0M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$197.5M -$235.8M -$151.1M -$216.2M -$381.1M -$10.66M -$5.06M
Depreciation & Amortization $921K $942K $810K $131K $34K $0 $6.0K
Stock-Based Compensation $30.96M $33.55M $29.39M $24.96M $14.85M $336K $236K
Change in Payables $50K -$4.58M -$2.72M $6.35M $4.16M -$49K $855K
Operating Cash Flow -$193.8M -$142.1M -$160.3M -$200.5M -$135.1M -$10.63M -$5.83M
Capital Expenditure -$371K -$34K -$169K -$1.14M -$186K $0 $0
Free Cash Flow -$194.2M -$142.1M -$160.5M -$201.7M -$135.3M -$10.63M -$5.83M
Purchases of Investments -$739.8M -$140.5M -$264.9M $0 -- -- --
Investing Cash Flow -$418.5M $31.27M -$127.0M -$931K $63.26M $0 $0
Common Stock Issued -- -- $20.81M $0 -- -- --
Share Repurchases -- -- -- -- -$12K $0 $0
Financing Cash Flow $291.5M $364.8M $21.12M $457K $660.1M $1.36M $9.01M
Net Change in Cash -$321.3M $255.2M -$265.6M -$201.4M $590.1M -$9.34M $3.70M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Net Income -$79.24M -$66.16M -$54.89M -$50.34M -$26.14M -$111.3M -$42.57M -$43.82M
Depreciation & Amortization $239K $241K $237K $226K $217K $230K $236K $236K
Stock-Based Compensation $10.56M $7.94M $7.19M $7.95M $7.88M $8.33M $8.45M $8.61M
Change in Payables $3.26M -$1.31M $3.28M $177K -$2.10M $143K $1.71M -$2.18M
Operating Cash Flow -$72.22M -$55.81M -$58.31M -$22.45M -$57.25M -$42.80M -$21.39M -$40.58M
Capital Expenditure -- -- -- -- -- $0 -$34K $0
Free Cash Flow -- -- -- -- -- -$42.80M -$21.42M -$40.58M
Purchases of Investments -$75.54M -$313.7M -$45.51M -$83.06M -$297.5M $0 $0 -$120.5M
Investing Cash Flow $42.71M -$218.1M $61.95M -$39.95M -$222.4M $25.00M $44.96M -$55.46M
Common Stock Issued $0 -- -- -- $6.11M -- -- --
Financing Cash Flow $30.47M $283.4M $3.44M $1.60M $3.09M $2.96M $246.0M $105.3M
Net Change in Cash $1.13M $11.14M $6.57M -$60.91M -$278.1M -$11.80M $267.7M $9.15M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -1384.6% -- -2499.4% -- -- -- --
Net Profit Margin -1316.9% -- -2204.7% -- -- -- --
Return on Equity (ROE) -37.5% -58.7% -64.0% -64.3% -77.5% -- --
Return on Assets (ROA) -28.7% -40.9% -41.9% -48.7% -60.5% -91.0% --
Current Ratio 8.57x 9.25x 8.00x 11.42x 25.52x 1.30x --
Quick Ratio 6.86x 8.31x 6.51x 10.27x 24.15x 0.84x --
Debt to Equity 0.22x 0.29x 0.36x 0.21x 0.15x -- --
Revenue Growth (YoY) -- -100.0% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Operating Margin -- -1384.6% -1425.3% -1376.1% -1304.9% -- -- --
Net Profit Margin -- -1316.9% -1618.0% -1535.8% -1492.3% -- -- --
Return on Equity (ROE) -51.4% -37.5% -80.5% -66.8% -58.0% -58.7% -32.3% -54.8%
Return on Assets (ROA) -39.1% -28.7% -54.1% -46.8% -42.4% -40.9% -26.4% -39.5%
Current Ratio 9.53x 8.57x 10.57x 10.12x 14.37x 9.25x 21.52x 13.29x
Quick Ratio 7.56x 6.86x 8.45x 8.44x 11.76x 8.31x 19.63x 11.02x
Debt to Equity 0.24x 0.22x 0.39x 0.34x 0.31x 0.29x 0.17x 0.30x
Revenue Growth (YoY) -100.0% -- -- -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001847903) · from December 31, 2019 Data through March 31, 2026 · synced Nov 20, 2026, 05:14 UTC · Open in terminal